Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.
Shakti ShresthaArjun PoudelKathryn J SteadmanLisa M NissenPublished in: British journal of clinical pharmacology (2019)
Our findings suggest that deprescribing in older patients with LLI and LLE can improve medication appropriateness, and has potential for enhancement of several clinical outcomes and cost savings, but the evidence needs to be better established.